Pacira BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	21.44	-99.56	41.96	15.91	41.98	145.52
Depreciation & Amortization	85.42	78.79	75.57	81	28.55	19.91
Other Amortization	3.29	3.22	3.75	7.21	25.91	20.41
Loss (Gain) From Sale of Assets	-	-	-	-	-	0.02
Asset Writedown & Restructuring Costs	31.37	163.24	-	36.63	-	-
Loss (Gain) From Sale of Investments	11	-	-	10	-	-1.62
Stock-Based Compensation	56.27	51.17	47.9	48.09	42.25	39.92
Other Operating Activities	9.96	11.05	31.25	-37.14	12.55	-113.34
Change in Accounts Receivable	-14.59	-7.75	-7.16	-2.08	-10.43	-5.52
Change in Inventory	-45.8	-20.93	-8.29	2.49	-4.47	-6.35
Change in Accounts Payable	-2.99	3.08	0.92	6.27	-10.26	-3.31
Change in Other Net Operating Assets	-13.92	7.07	-31.24	-23.11	-0.35	-18.61
Operating Cash Flow	141.44	189.39	154.65	145.27	125.72	77.03
Operating Cash Flow Growth	-30.61%	22.46%	6.45%	15.56%	63.20%	9.23%
Capital Expenditures	-17.23	-10.64	-15.16	-30.08	-45.87	-37.8
Cash Acquisitions	-16.7	-	-	-32	-424.04	-
Investment in Securities	113.72	-72.64	92.7	-163.11	449.12	-239.81
Investing Cash Flow	79.78	-83.28	77.54	-225.19	-20.79	-277.61
Long-Term Debt Issued	-	287.5	149.55	-	363.75	314.71
Long-Term Debt Repaid	-	-210.89	-330.31	-427.69	-	-176.79
Net Debt Issued (Repaid)	-214.61	76.62	-180.76	-427.69	363.75	137.92
Issuance of Common Stock	2.52	2.3	4.75	27.34	26.66	135.56
Repurchase of Common Stock	-105.63	-25.49	-0.11	-	-	-33.09
Other Financing Activities	-2.2	-36.06	-6.91	-1.18	-9.71	-18.08
Financing Cash Flow	-319.93	17.36	-183.03	-401.53	380.69	222.3
Net Cash Flow	-98.38	123.48	49.16	-481.44	485.62	21.73
Free Cash Flow	124.2	178.75	139.49	115.2	79.85	39.23
Free Cash Flow Growth	-35.82%	28.15%	21.09%	44.27%	103.54%	-35.01%
Free Cash Flow Margin	17.33%	25.50%	20.67%	17.28%	14.74%	9.13%
Free Cash Flow Per Share	2.71	3.87	2.68	2.48	1.75	0.90
Cash Interest Paid	15.62	15.42	27.64	33.3	7	7.21
Cash Income Tax Paid	10.39	11.02	4.37	7.4	3.22	2.42
Levered Free Cash Flow	78.4	163.38	107.15	92	49.79	38.75
Unlevered Free Cash Flow	86.5	170.52	116.09	109.78	43.72	34.39
Change in Working Capital	-77.31	-18.52	-45.78	-16.43	-25.51	-33.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.